NOUL

Biotechnology Research • 338, Gwanggyojungang-ro, Korea, Republic of • 51-100 Employees

Company overview

Headquarters	338, Gwanggyojungang-ro, Suji-gu, Yongin-si,, Umi-Newv Intelligence Industry Center, B, 10th Floor, Yongin-si, Gyeonggi-do 16942, KR
Phone number	+82313086310
Website	noul.com
NAICS	541714
SIC	566
Keywords	Mobile Technology, HIV, Healthcare, Chemistry, Diagnostics, Robotics, Aids, Artificial Intelligence, Software Engineering, Accessibility, Blockchain, International Development, Biology, Malaria, Tuberculosis, Material Science, Lab On A Chip, Point Of Care, Medical Data, Hermatology
Founded	2015
Employees	51-100
Socials

Key Contacts at NOUL

David Lim

Founder & Ceo

Daniel Jeong

전무 Managing Director

Youngmin Shin

Co-Founder / Computer Vision Engineer

Mijin Kim

Director

NOUL Email Formats

NOUL uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@noul.com), used 58.8% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@noul.com	58.8%
{first name}	john@noul.com	35.3%
{first initial}.{last name}	j.doe@noul.com	5.9%

About NOUL

Noul Inc. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing. Noul’s solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering. Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions. [Mission] We explore global challenges that threaten human health and life, discover novel potential solutions, and realize those possibilities. [Goal] 1. To contribute to eliminating malaria, tb, aids and other neglected diseases through innovative diagnostic platform. 2. To proactively increase healthcare accessibility through next-generation blood diagnostics platform.

NOUL revenue & valuation

Annual revenue	$7,871,060
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$25,200,000
Total funding	$3,100,000